Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Mineralys Therapeutics
MLYS
$2.27B
| $409K | ﹤0.01% |
31,700
+6,200
| +24% | +$76.6K |
|
2952
Schwab Fundamental International Small Company Index ETF
FNDC
$3.18B
| $408K | ﹤0.01% |
+11,500
| New | +$395K |
|
2953
Pyxis Tankers
PXS
$52.4M
| $408K | ﹤0.01% |
85,601
+21,284
| +33% | +$95.9K |
|
2954
Anavex Life Sciences
AVXL
$293M
| $407K | ﹤0.01% |
+79,900
| New | +$450K |
|
2955
Five Star Bancorp
FSBC
$1.16B
| $407K | ﹤0.01% |
18,100
+736
| +4% | +$17.6K |
|
2956
Radiant Logistics
RLGT
$413M
| $406K | ﹤0.01% |
74,970
-21,430
| -22% | -$127K |
|
|
LABP
2957
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $406K | ﹤0.01% |
18,890
+7,630
| +68% | +$50.6K |
|
2958
Ark Restaurants
ARKR
$20.2M
| $403K | ﹤0.01% |
29,311
-900
| -3% | -$12.8K |
|
2959
Trevi Therapeutics
TRVI
$2.58B
| $403K | ﹤0.01% |
116,842
-425,858
| -78% | -$950K |
|
|
SSKN
2960
DELISTED
Strata Skin Sciences
SSKN
| $402K | ﹤0.01% |
106,285
-460
| -0.4% | -$2.4K |
|
2961
JPMorgan International Research Enhanced Equity ETF
JIRE
$11.4B
| $401K | ﹤0.01% |
+6,400
| New | +$383K |
|
2962
USCB Financial Holdings
USCB
$419M
| $401K | ﹤0.01% |
35,211
-289
| -0.8% | -$3.34K |
|
|
DHC
2963
Diversified Healthcare Trust
DHC
$2.02B
| $398K | ﹤0.01% |
161,800
+118,164
| +271% | +$338K |
|
|
AIOS
2964
AIOS Tech
AIOS
$39.1M
| $398K | ﹤0.01% |
3,773
-1,910
| -34% | -$172K |
|
2965
Corbus Pharmaceuticals
CRBP
$195M
| $397K | ﹤0.01% |
+10,123
| New | +$250K |
|
2966
Union Bankshares
UNB
$120M
| $397K | ﹤0.01% |
13,032
+500
| +4% | +$15.2K |
|
2967
Highway Holdings
HIHO
$5.04M
| $396K | ﹤0.01% |
188,415
-2,000
| -1% | -$4.09K |
|
2968
First Trust Dorsey Wright Focus 5 ETF
FV
$3.81B
| $395K | ﹤0.01% |
+6,900
| New | +$372K |
|
2969
Cellectar Biosciences
CLRB
$20.6M
| $392K | ﹤0.01% |
+3,283
| New | +$356K |
|
|
KYNB
2970
Kyntra Bio
KYNB
$29.5M
| $391K | ﹤0.01% |
6,660
-20,676
| -76% | -$891K |
|
2971
Emerson Radio
MSN
$8M
| $391K | ﹤0.01% |
737,388
-5,800
| -0.8% | -$3.12K |
|
2972
Apogee Enterprises
APOG
$876M
| $390K | ﹤0.01% |
6,583
-7,500
| -53% | -$414K |
|
|
EDN
2973
Edenor
EDN
$1.01B
| $390K | ﹤0.01% |
22,024
+8,124
| +58% | +$147K |
|
2974
Acushnet Holdings
GOLF
$5.28B
| $389K | ﹤0.01% |
5,900
+1,500
| +34% | +$97.1K |
|
2975
Vanguard Real Estate ETF
VNQ
$39.2B
| $389K | ﹤0.01% |
+4,500
| New | +$384K |
|
Similar funds
Jim Simons's Q1 2024 Portfolio in Review
As of Q1 2024, Jim Simons held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Chevron worth $331M.
- Jim Simons's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Jim Simons added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Jim Simons's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Jim Simons fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Jim Simons's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Jim Simons opened 562 new positions and closed 582 in Q1 2024.
- Jim Simons's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.